POM-V Prescription Required

AVINEW NEO Effervescent Tablet for Suspension for Chickens and Turkeys

Active ingredient: Newcastle disease virus

Form

Tablet

Species

Chickens Turkeys

Manufacturer

Boehringer Ingelheim Animal Health UK Limited

VMD MA No.

08327/5043

What it's used for

In broiler chickens from the age of one day: - Active immunisation against Newcastle disease to reduce mortality and clinical signs associated with the dis...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Newcastle disease virus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

AVINEW NEO Effervescent Tablet for Suspension for Chickens and Turkeys — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

In broiler chickens from the age of one day:
- Active immunisation against Newcastle disease to reduce mortality and clinical
signs associated with the disease.
Onset of immunity: 14 days after primary vaccination.
Duration of immunity induced by the vaccination scheme described under section
4.9: protection until the age of 6 weeks.
In future layer and future breeder pullets from the age of 4 weeks:
- Priming for active immunisation against egg drop caused by Newcastle disease
before vaccination with an inactivated vaccine (strain Ulster 2C) prior to the
beginning of lay.
For duration of immunity of full schedule, see the leaflet of the inactivated booster
vaccine.
In turkeys from the age of one day:
- Active immunisation against Newcastle disease to reduce mortality and clinical
signs associated with the disease.
Onset of immunity: 21 days after primary vaccination.

Revised: May 2022
AN: 00820/2021 and 00821/2021
Duration of immunity: 7 weeks after a single administration.

In broiler chickens:
Primary vaccination by ocular route (eye drop application) or oculonasal
route (coarse spray application): from the age of one day.
Booster vaccination by oral route (drinking water application): at the age of 2 to 3
weeks. The minimal interval between the two vaccinations should be of 2 weeks.
In future layer and future breeder pullets:
Two administrations by ocular route (eye drop application), oculonasal route
(coarse spray application) or oral route (drinking water application): at the age of
4 weeks and 8 weeks. Vaccination with the product should be followed by
vaccination with an inactivated vaccine (strain Ulster 2C) prior to the beginning of
lay to provide sufficient efficacy.
In turkeys:
Vaccination by oculonasal route (coarse spray application): from the age of one day.
Method of administration:
To reconstitute and prepare the vaccine, use clean cold water.
For the preparation and administration of the vaccine, use clean material free from
disinfectant and/or antiseptic.
Wait until complete dissolution of the tablets before using the vaccine solution.
The reconstituted vaccine is a blue solution, and a fine foam layer may form over
the surface.
- Individual vaccination: ocular use
For 1,000 birds, dissolve a 1,000-doses tablet into 50 ml of boiled and cooled non
chlorinated drinking water prepared in a clean container free from disinfectant and/or
antiseptic. Wait until complete dissolution of the tablet, then use a syringe to transfer
the vaccine solution to the dropper. It is recommended to prepare the vaccine in a
clean area separate from the animals.
Use a calibrated dropper, so as to distribute 50 µl-drops.
Place one drop of the vaccine solution on the eye of each bird, allow the drop to
spread and release the bird.
- Mass vaccination, oral route:
For 1,000 birds, dissolve a 1,000-doses tablet into the volume of non chlorinated
drinking water to be consumed within one to two hours.
When using mains water, treat all water to come into contact with the vaccine
with skimmed milk powder at a rate of 2.5 g per litre in order to neutralise traces
of chlorine.
Distribute the vaccine solution to the birds. Birds should be deprived of water for
two hours prior to vaccination.

Revised: May 2022
AN: 00820/2021 and 00821/2021
- Mass vaccination, coarse spray application:
For 1,000 birds, dissolve a 1,000-doses tablet in the volume of non
chlorinated drinking water appropriate for the type of sprayer used (pressure-
sprayer or sprayer with rotary cone).
Spray the vaccine solution above the birds using a spray capable of producing
micro-droplets (mean diameter 80-100 µm).
For proper vaccine distribution, make sure that birds are closely confined together
during spraying. The ventilation system of the poultry house should be inoperative
during the spray administration.

None.

None known.
In future layer and future breeder pullets, refer to the leaflet of the inactivated booster
vaccine.

Vaccinate healthy birds only.

Special precautions for use in animals
Vaccine virus can spread to unvaccinated birds. In turkeys, this spread has been
shown to be less than 21 days after administration of a 10-time overdose. Infection
of unvaccinated birds with the vaccine virus from vaccinated birds does not induce
any sign of disease. Moreover, a reversion to virulence trial carried out in the
laboratory has shown that the vaccine virus does not acquire any pathogenic
characteristic after 10 passages in chickens. Therefore, spread to unvaccinated
birds, in the present state of knowledge, can be considered as safe.
In turkeys, the onset of immunity was evaluated in SPF seronegative birds. The
impact of maternally derived antibodies on the immediate response to vaccination
in turkeys is unknown. The duration of immunity was studied in the presence of
maternally derived antibodies.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Care should be taken when handling the vaccine solution.
Newcastle disease virus can cause a transitory conjunctivitis in man. Since this
vaccine has been prepared with live, attenuated microorganisms, appropriate
measures should be taken to prevent contamination of the handler and other people
that collaborate in the process. Therefore, during preparation and administration of
the vaccine suspension, it is recommended to wear respiratory and eye protection in
compliance with current European standards. For more information, contact the
manufacturer.
Hands should be washed and disinfected after vaccinating.

No information is available on the safety and efficacy of this vaccine when
used with any other veterinary medicinal product. A decision to use this
vaccine before or after any other veterinary medicinal product therefore needs
to be made on a case by case basis.

Store and transport refrigerated (2°C-8°C).
Do not keep unused tablets removed from the blister.
Keep the blisters in the outer carton.

(*) EID50: Egg Infective Dose 50 per cent.
Excipients:
Brilliant blue FCF (E 133)
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.